A community-based intervention using Akarkara to enhance the muscle mass and sexual activity: a randomized controlled trial
Phase 3
Completed
- Registration Number
- CTRI/2021/05/033694
- Lead Sponsor
- Stiriti Ayur Therapies pvt ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 448
Inclusion Criteria
Less Muscle Mass
Decreased erection
Decreased hair growth in face, axilla and pubic regions
Insomnia
Exclusion Criteria
Hospitalised patients
Subjects with Cancer, HIV/AIDS, Life threatening conditions
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Change in mid upper arm circumference <br/ ><br>Change in frequency of sexual intercourse in a week <br/ ><br>Change in duration of penile erectionTimepoint: Baseline <br/ ><br>3 weeks <br/ ><br>2 months
- Secondary Outcome Measures
Name Time Method Change in length of hair over beard, axilla, pubic region <br/ ><br>Change in duration of sleepTimepoint: 3 weeks <br/ ><br>2 months
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does Spilanthes acmella modulate to enhance muscle hypertrophy and sexual function?
How does Stiriti Ayur Therapies' Spilanthes acmella intervention compare to testosterone therapy in improving muscle mass and libido?
Which biomarkers correlate with improved outcomes in CTRI/2021/05/033694's herbal muscle and sexual health trial?
What adverse events were reported in phase III trials of Spilanthes acmella for muscle mass enhancement?
Are there synergistic effects of combining Spilanthes acmella with resistance training or phosphodiesterase inhibitors?